Increasing Receipt of Guideline Concordant Survivorship Care Among Black Breast Cancer Survivors
Black women experience significant disparities in breast cancer across the care continuum including survivorship. Black women of diverse ethnic backgrounds, particularly those of lower socioeconomic status are less likely to receive guideline concordant survivorship care including: 1) Surveillance for breast cancer recurrence and/or second primary breast cancer; 2) Assessment and management of long-term physical and psychosocial effects of breast cancer and treatment; 3) Healthy lifestyle promotion and maintenance; 4) Care coordination between oncology and primary care. Multiple studies have demonstrated that the transition from active treatment to breast cancer survivorship is fraught with confusion and anxiety for many patients.
The clinical transition from oncology specialist care back to a primary care provider (PCP) is complicated by difficulties in communication and lack of PCP training on cancer survivorship care. Second, patients often are unsure what to expect and lack information. While survivorship care plans have been promoted, they do not fully address patient and provider needs. This project will develop a survivorship education program for patients and PCPs. It builds upon an existing cancer survivorship education program for primary care providers at local health centers and will be conducted in partnership with multiple local organizations including Boston Medical Center, the Boston Breast Cancer Equity Coalition, Boston Public Health Commission, and three local health centers.
Impact of a Comprehensive Patient Navigation Intervention on Endocrine Therapy Adherence and Persistence among Vulnerable Women in Boston
Data suggest that up to 50% of women do not complete five years of endocrine therapy, and this may be even worse among lower income and minority women and may contribute to persistent racial and socioeconomic disparities in breast cancer survival. Previous interventions to address gaps in endocrine therapy (ET) initiation, adherence and persistence have focused on education and cognitive behavioral training among patients, with limited success, however, a small, but growing body of evidence demonstrates system level interventions may be effective. Translating Research into Practice (TRIP) is a three-pronged city-wide patient navigation intervention targeted at breast cancer patients who are at risk for delays in care due to their race/ethnicity, language, or insurance status. We propose to: 1) Determine the feasibility and validity of an online medication database compared to EMR data abstraction to measure ET adherence and persistence; and 2) Evaluate the impact of TRIP on ET early discontinuation and adherence among 342 intervention patients and 263 historic controls with HR+ breast cancer.